News - Teijin

Filter

Current filters:

Teijin

Popular Filters

Teijin and Amgen join forces on autoimmune disease research

31-07-2013

Japan's Teijin Pharma, the core company of the Teijin Group's (TSE: 3401) health care business, has entered…

AmgenBiotechnologyImmunologicalsInflammatory diseasesLicensingPharmaceuticalResearchTeijin

Teijin collaborates with InCube Labs to boost health care business

22-01-2013

Japan's Teijin (TYO: 3401) says it has signed a strategic partnership agreement with InCube Labs, a California-based…

InCube LabsMergers & AcquisitionsPharmaceuticalResearchTeijin

Teijin and Ipsen's Somatuline cleared in Japan

01-07-2012

Japanese drugmaker Teijin Pharma (TYO: 3402) revealed last Friday that it has received manufacturing…

Asia-PacificIpsenPharmaceuticalRare diseasesRegulationSomatulineTeijin

Menarini extends febuxostat accord to more regions

12-04-2012

Japanese drugmaker Teijin Pharma and privately-owned Italian pharmaceutical company Menarini have signed…

febuxostatGenito-urinaryLicensingMenariniPharmaceuticalTeijin

NovAliX in drug discovery collaboration with Teijin Pharma

13-01-2012

French company NovAliX has entered into a multi-target integrated drug discovery collaboration with Japanese…

Asia-PacificEuropeNovAliXPharmaceuticalResearchTeijin

Teijin and Astellas expand collaboration on gout drug febuxostat

12-08-2011

Japanese drugmakers Teijin Pharma (TYO: 3401 and Astellas Pharma (TKO:4503) have entered into an exclusive…

Anti-Arthritics/RheumaticsAsia-PacificAstellas PharmafebuxostatLicensingPharmaceuticalTeijin

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top